A strategic approach in favour of cross-border cooperation in the pharmaceutical and biopharmaceutical industry.
The partnership started back in 2013, focusing mainly on the organisation of Meetings for the Biohealth Industries of New Aquitaine, Basque Country, and Navarre (RNAEN). Last Thursday, 12 May 2022, the French pharmaceutical industrial cluster Polepharma-GIPSO and the Basque Health Cluster formalised their mutual commitment by signing an agreement at the Euroregion’s facilities (New Aquitaine, Basque Country, and Navarre) in the city of Hendaye.
By doing so, Mikel Álvarez Yeregui (President of the Basque Health Cluster ) and Fabien Riolet (General Director of Polepharma GIPSO) reaffirmed their desire to promote exchanges and cooperation between their respective members.
This cross-border alliance will certainly serve to support industrial pharmaceutical relocation and strengthen European sovereignty in the health care sector.
About Polepharma:
POLEPHARMA is the first European pharmaceutical cluster. It is the network of excellence and innovation in the pharmaceutical and biopharmaceutical production sector in France. Made in France. With a strong territorial establishment and members spread throughout the French geography, Polepharma has unrivalled legitimacy and is renowned within its sector.
Polepharma promotes collaboration and boldness to support the competitiveness, innovation, and attractiveness of the stakeholders of the French pharmaceutical sector. It has a team of experts at the service of the network specialising in Bioproduction, Research and Development, Industrial Operations, Regulatory Affairs, and Human Resources Training. Founding Historical Territory: Centre – Loire Valley, Normandy, Île-de-France, and new facilities in New Aquitaine-Occitania with its GIPSO network. It has members throughout the French territory.
Key figures
- The first exporter of medicines in France, with a turnover of 26 billion euros in exports and responsible for 60% of the production of medicines in France.
- An ecosystem of over 360 agents (laboratories, suppliers, transformers, public and private institutions, universities, and research and training centres, etc.).
- More than 70,000 employees spread across all stakeholders in the sector.
- 5 Polepharma offices in Chartres, Louviers, Tours, Bordeaux, and Paris.
Philippe Ivanes: President of Polepharma and Industrial Director of the Antithrombotic Division of SANOFI
Fabien Riolet: General Manager of Polepharma
